A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31) - PubMed (original) (raw)

A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31)

W A Muller et al. J Exp Med. 1992.

Abstract

The molecular nature of cell adhesion mediated by platelet/endothelial cell adhesion molecule 1 (PECAM-1; CD31) was examined using stably transfected L cells in a PECAM-dependent aggregation assay. This adhesion was temperature sensitive and divalent cation dependent, with Mg2+ supporting aggregation to a greater degree than Ca2+. PECAM-dependent aggregation was heterophilic: PECAM-1 transfectants bound as readily to control-transfected L cells as to other PECAM-1 transfectants, demonstrating that a molecule endogenously expressed on the L cells serves as the ligand for PECAM in this system and presumably substitutes for the natural human ligand.

PubMed Disclaimer

Similar articles

• Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties.
  DeLisser HM, Chilkotowsky J, Yan HC, Daise ML, Buck CA, Albelda SM. DeLisser HM, et al. J Cell Biol. 1994 Jan;124(1-2):195-203. doi: 10.1083/jcb.124.1.195. J Cell Biol. 1994. PMID: 8294502 Free PMC article.
• Functional regulation of platelet/endothelial cell adhesion molecule-1 by TGF-beta 1 in promonocytic U-937 cells.
  Lastres P, Almendro N, Bellón T, López-Guerrero JA, Eritja R, Bernabéu C. Lastres P, et al. J Immunol. 1994 Nov 1;153(9):4206-18. J Immunol. 1994. PMID: 7930623
• The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo.
  Muller WA. Muller WA. J Leukoc Biol. 1995 Apr;57(4):523-8. doi: 10.1002/jlb.57.4.523. J Leukoc Biol. 1995. PMID: 7722409 Review.
• The role of PECAM-1 in vascular cell biology.
  Newman PJ. Newman PJ. Ann N Y Acad Sci. 1994 Apr 18;714:165-74. doi: 10.1111/j.1749-6632.1994.tb12041.x. Ann N Y Acad Sci. 1994. PMID: 8017765 Review.

Cited by

• Expression of PECAM-1/CD31 isoforms in human brain gliomas.
  Aroca F, Renaud W, Bartoli C, Bouvier-Labit C, Figarella-Branger D. Aroca F, et al. J Neurooncol. 1999 May;43(1):19-25. doi: 10.1023/a:1006233816724. J Neurooncol. 1999. PMID: 10448867
• PECAM-1 (CD31) expression modulates bleeding time in vivo.
  Mahooti S, Graesser D, Patil S, Newman P, Duncan G, Mak T, Madri JA. Mahooti S, et al. Am J Pathol. 2000 Jul;157(1):75-81. doi: 10.1016/S0002-9440(10)64519-1. Am J Pathol. 2000. PMID: 10880378 Free PMC article.
• PECAM-1 is required for transendothelial migration of leukocytes.
  Muller WA, Weigl SA, Deng X, Phillips DM. Muller WA, et al. J Exp Med. 1993 Aug 1;178(2):449-60. doi: 10.1084/jem.178.2.449. J Exp Med. 1993. PMID: 8340753 Free PMC article.
• The biology of PECAM-1.
  Newman PJ. Newman PJ. J Clin Invest. 1997 Jan 1;99(1):3-8. doi: 10.1172/JCI119129. J Clin Invest. 1997. PMID: 9011572 Free PMC article. Review. No abstract available.
• Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses.
  Prager E, Sunder-Plassmann R, Hansmann C, Koch C, Holter W, Knapp W, Stockinger H. Prager E, et al. J Exp Med. 1996 Jul 1;184(1):41-50. doi: 10.1084/jem.184.1.41. J Exp Med. 1996. PMID: 8691148 Free PMC article.

References

1. 1. Proc Natl Acad Sci U S A. 1990 May;87(9):3589-93 - PubMed
2. 1. Dev Biol. 1984 Jan;101(1):19-27 - PubMed
3. 1. J Exp Med. 1989 Aug 1;170(2):399-414 - PubMed
4. 1. J Cell Biol. 1987 Mar;104(3):725-31 - PubMed
5. 1. Nature. 1986 Apr 3-9;320(6061):445-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal